FINWIRES · TerminalLIVE
FINWIRES

$LCTX

1 story mentioning LCTXUpdated 43d ago

Every FINWIRES story that references LCTX, newest first.

Research

Canaccord Genuity Initiates Coverage on Lineage Cell Therapeutics With Buy Rating, $9 PT

$LCTX

Track with the FINWIRES app suite

FolioX
FolioX
Track LCTX in your portfolio
WheelAI
WheelAI
Analyze LCTX options with the wheel strategy
StockInsider
StockInsider
See market sentiment on LCTX